Product
ADT + Apalutamide
Name
ADT + Apalutamide
1 clinical trial
4 drugs
4 indications
Indication
Prostate CancerIndication
OligometastasisIndication
Oligo-recurrenceIndication
Recurrent Prostate CancerDrug
DocetaxelDrug
apalutamideClinical trial
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer (VA STARPORT)Status: Recruiting, Estimated PCD: 2025-07-01